Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02362594 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054) |
| First Submitted : | February 9, 2015 |
| First Submitted that Met QC Criteria : | February 9, 2015 |
| First Posted : | February 13, 2015 (Estimate) |
| Results First Submitted : | December 10, 2018 |
| Results First Submitted that Met QC Criteria : | December 10, 2018 |
| Results First Posted : | January 4, 2019 |
| Last Update Submitted that Met QC Criteria : | July 31, 2023 |
| Last Update Posted : | August 21, 2023 |